[Amphoglucamine in the combined chemotherapy of viral diseases].
Shneĭder
M A
MA
Golovkin
V I
VI
Chizhov
N P
NP
Shtil'bans
E B
EB
D000666:Amphotericin B / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D000818:Animals; D002642:Chick Embryo; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D009980:Influenza A virus / Q000187:drug effects; D007251:Influenza, Human / Q000188:drug therapy*; D008297:Male; D051379:Mice; D009103:Multiple Sclerosis / Q000188:drug therapy*; D012299:Rimantadine / Q000627:therapeutic use; D013994:Tilorone / Q000627:therapeutic use; D014779:Virus Replication / Q000187:drug effects
D012299:Rimantadine; C023999:amphoglucamine; D000666:Amphotericin B; D013994:Tilorone
Amfogliukamin v kompleksnoĭ khimioterapii nekotorykh virusnykh zabolevaniĭ.